Replies to post #18577 on Pluristem Therapeutics Inc (PSTI)

[hopester]

That article on Pluristems "questionable ethics " was written in Feb.2015.

All the amazing trial results since that time were as a result of work performed by Doctors, medical scientists, in accredited hospitals and labs...... around the world and independent.
The reports are seen to be accurate and fairly reported.
I've have to conclude that the conductors are honest, ethical and accurate.
Perhaps the publisher of the piece should write another article praising Pluristem for it's work.

[Scott999]

Funny the 4 main points are still valid

1 “Pluristem has a long history of ethically questionable reporting to investors”

Still have yet to become transparent in any way whatsoever. No CC’s, no updates of relevance, milestones have disappeared altogether. If anything, it’s much worse.

2 “Stock price jumps ostensibly on analysis published by a discredited bucket shop”

Have a look at the pump from Oct last year and where we are since that raise.

3 “Heavy dilution is imminent and could have a significant negative effect on the share price.”

Three raises since then and an ongoing ATM. The most critical time with regards to financing is imminent. Have to figure out something soon or will get much worse quickly.

4 “Top executives have zero educational and professional experience in the biotech field”

The number one relevant point of them all. If anything, they have promoted inexperienced people and hired even more with little to no experience.